Series A - Corteria Pharmaceuticals
Investment Firm
Overview
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.
Announced Date
Sep 07, 2023
Funding Type
Series A
Highlights
Location
Europe
Social
Participant Investors
7
Round Details and Background
Corteria Pharmaceuticals raised $69538574 on 2023-09-07 in Series A
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 09, 2021 |  Seed Round - Corteria Pharmaceuticals | 4 | - | 13.6M |
| Sep 07, 2023 | Series A - Corteria Pharmaceuticals | 7 | - | 69.5M |